Der Healthtech Capital Investor.
Empowering innovation that improves lives
über uns
verstehen, beraten & gestalten
MTIP ist ein wachsender paneuropäischer Healthtech Growth Capital Investor mit Sitz in Basel, Schweiz. Wir investieren in Unternehmen der digitalen Gesundheit und der digital vernetzten Medizintechnik, deren Angebote einen klaren gesundheitsbezogenen und wirtschaftlichen Nutzen anbieten. Unser Investmentteam, das über umfassende Private-Equity-Kenntnissen verfügt, arbeitet aktiv mit unseren Portfoliounternehmen zusammen, um deren Wachstum zu fördern. MTIP setzt das Kapital effizient ein, um Werte freizusetzen und attraktive Gewinne für unsere Investoren zu erzielen.
Portfolio
unsere Erfolgsgeschichten
CEO von Cynerio
Mitgründer und CEO von TytoCare
Mitgründer und CEO von Oviva
stories
Trends und Inputs von unseren Experten bei MTIP
Diversity, Equity, and Inclusion: The 3 Key Drivers for Success – An Interview with Caroline Noublanche
Dieser Text erscheint auf allen Übersichtsseiten (z.B. Story-Karussell)
Growth Capital Decisions – An Interview with our Co-Founder & Managing Partner Dr. Christoph Kausch
MTIP Co-Founder and Managing Partner Dr. Christoph Kausch gives insight into growth capital decisions.
Rahel Hafner passed the Certificate in ESG Investing by CFA Institute
Rahel Hafner Receives Certificate in ESG Investing
MTIP’s HealthCare Clinic 2022
This year's HealthCare Clinic was held unter the motto: „Surfing the Healthtech Waves of Change“.
What Makes a Great Founder/Investor Relationship?
Interview with the CEO and Co-Founder Kai Eberhardt of our portfolio company Oviva
Christoph Kausch selected by Real Deals as most influential for 2022
Christoph Kausch named by Real Deals most influential for 2022
MTIP leads €17 million financing round in virtual fertility clinic Apricity
New MTIP investment
MTIP leads the €20 million growth financing round in LynxCare
Largest capital round ever in digital health in Belgium
Pioneering the use of machine learning algorithms to turbo-charge drug development
Intelligencia revolutionizes drug development
MTIP schliesst zweiten Healthtech Growth Fonds mit $250 Millionen
MTIP schliesst zweiten Healthtech Fund
Cynerio Now! – A new IoT cybersecurity solution for small hospitals and clinics
Cynerio's new product Cynerio Now!
MTIP invests in Mediktor
Dieser Text erscheint auf allen Übersichtsseiten (z.B. Story-Karussell)
SFDR Art. 8 or Art. 9? What’s the difference?
SFDR: getting the terminology right
MTIP participates in Oviva’s new $80m Series C funding
MTIP invests in Oviva
MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence
MTIP's new investment in Intelligencia
Leading brands revolutionize care journeys with Lumeon
How Lumeon orchestrates care journey
Trialbee – our hero in patient matching and recruiting for clinical trials
Trialbee - patient matching and recruiting
Digital healthcare: patient-first?
Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital
SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?
New SFDR obligations
MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation
First Closing of Fund II
MTIP invests in Koa Health to make mental health treatment more accessible
New investment in Koa Health
MTIP scored fantastic grades in the UNPRI assessment report of 2020
UNPRI Report grades 2020
Newsletter
